Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01436214
Recruitment Status : Unknown
Verified July 2015 by Adamis Pharmaceuticals Corporation.
Recruitment status was:  Active, not recruiting
First Posted : September 19, 2011
Last Update Posted : July 16, 2015
Information provided by (Responsible Party):
Adamis Pharmaceuticals Corporation

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2016
  Estimated Study Completion Date : August 2017